SavedAdd your journal

Journals / InTraders Uluslararası Ticaret Akademik Dergisi / 2026 / Volume: 9 Issue: Special Issue Special Issue

Supply Chain Vulnerability in Health Systems: Management of Medical Supplies Import Dependency in Türkiye

Nihal Kalaycı Oflaz(ISTANBUL MEDIPOL UNIVERSITY)0000-0002-8252-5868
Olcay Özen(ISTANBUL MEDIPOL UNIVERSITY)0000-0001-6562-8286
Yurdagül Meral(ISTANBUL MEDIPOL UNIVERSITY)0000-0001-9244-1994
Pages
—
Publication Date
2026-10-28
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The findings also have policy implications, highlighting the need to strengthen domestic production capacity, establish strategic stock mechanisms for critical medical products, diversify suppliers, and develop adaptive supply management strategies to enhance the resilience and sustainability of Türkiye's health system during economic and global supply chain crises.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study examines the evolution of Türkiye's dependence on imported medical products and its association with health supply vulnerability from 2002 to 2024.
📊
Key Findings & Data:Guided by Resource Dependence Theory, a Health Supply Vulnerability Index (HSVI) was constructed from three dimensions: import dependency, exchange rate sensitivity, and financial pressure.
💡
Conclusion & Impact:The findings also have policy implications, highlighting the need to strengthen domestic production capacity, establish strategic stock mechanisms for critical medical products, diversify suppliers, and develop adaptive supply management strategies to enhance the resilience and sustainability of Türkiye's health system during economic and global supply chain crises.
🔬Design:Research Article
📍Scope:2002 Verileri
⚙️Variables:Health Economics · medical imports · health supply chain

Abstract

This study examines the evolution of Türkiye's dependence on imported medical products and its association with health supply vulnerability from 2002 to 2024. Guided by Resource Dependence Theory, a Health Supply Vulnerability Index (HSVI) was constructed from three dimensions: import dependency, exchange rate sensitivity, and financial pressure. Medical imports were converted from U.S. dollars to Turkish lira before the import-dependency ratio was calculated; public health expenditure and gross domestic product were expressed in compatible units; and all three indicators were transformed to a common 0-1 scale using Min-Max normalization. The normalized indicators were aggregated with equal weights, and robustness was examined using three alternative weighting schemes together with Pearson, Spearman, Kendall, absolute-deviation, and rank-stability measures. The HSVI reached its highest value in 2022 (0.640), followed by 2021 (0.612) and 2020 (0.551). These results identify periods of comparatively greater exposure to import dependence, exchange-rate movements, and fiscal pressure; they do not establish causal effects or directly measure product shortages. The findings also have policy implications, highlighting the need to strengthen domestic production capacity, establish strategic stock mechanisms for critical medical products, diversify suppliers, and develop adaptive supply management strategies to enhance the resilience and sustainability of Türkiye's health system during economic and global supply chain crises.

🔖

Cite This Article

Oflaz, N. K., Özen, O., Meral, Y. (2026). Supply Chain Vulnerability in Health Systems: Management of Medical Supplies Import Dependency in Türkiye. InTraders Uluslararası Ticaret Akademik Dergisi, Volume: 9 Issue: Special Issue Special Issue. https://doi.org/10.55065/intraders.1999286

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (54)

  1. Al Asfoor, D., Tabche, C., Al-Zadjali, M., Mataria, A., Saikat, S., & Rawaf, S. (2024). Concept analysis of health system resilience. Health research policy and systems, 22(1), 43. https://doi.org/10.1186/s12961-024-01114-w
  2. AlGhamdi, S., Aljuffali, I. A., Aljedai, A. H., Aljaser, R., Aljumah, M., Maskineh, C., Aldibasi, O., Sleilaty, G., & Alagil, N. A. (2026). Current generics utilization and associated savings in Saudi Arabia: Insights from a private claims database. Value in Health Regional Issues, 52, 101138 (1-7). https://doi.org/10.1016/j.vhri.2025.101138
  3. Allani, F., Zerei, S., Daghfous, S., Mhidi, R., Fenina, N., & Cherif, D. (2026). Trends in consumption and expenditures of targeted anticancer therapies in Tunisia. Journal of Cancer Policy, 47, 100720 (1-7). https://doi.org/10.1016/j.jcpo.2026.100720
  4. Ansmann, L., Vennedey, V., Hillen, H. A., Stock, S., Kuntz, L., Pfaff, H., Mannion, R., Hower, K. I., & Cologne Research and Development Network CoRe-Net Study Group CRADNCSG. (2021). Resource dependency and strategy in healthcare organizations during a time of scarce resources: Evidence from the metropolitan area of Cologne. Journal of Health Organization and Management, 35(9), 211–227. https://doi.org/10.1108/JHOM-12-2020-0478
  5. Balkhy, H. (2025). Accelerating access to medical products in the Eastern Mediterranean Region. Eastern Mediterranean Health Journal, 31 (5), 303-305. https://doi.org/10.26719/2025.31.5.303
  6. Barış, E., Silverman, R., Wang, H., Zhao, F., & Pate, M. A. (2022). Walking the talk: Reimagining primary health care after COVID-19. World Bank. https://doi.org/10.1596/978-1-4648-1768-7
  7. Barroy H., & Gupta S. (2021). Fifteen years later: moving forward Heller's heritage on fiscal space for health. Health Policy and Planning, 36(8):1239-1245. https://doi.org/10.1093/heapol/czab033
  8. Blanchet, K., Nam, S. L., Ramalingam, B., & Pozo-Martin, F. (2017). Governance and capacity to manage resilience of health systems: Towards a new conceptual framework. International Journal of Health Policy and Management, 6(8), 431–435. https://doi.org/10.15171/ijhpm.2017.36
  9. Brekke, K. R., Holmås, T. H., & Straume, O. R. (2015). Price regulation and parallel imports of pharmaceuticals. Journal of Public Economics, 129, 92–105. https://doi.org/10.1016/j.jpubeco.2015.08.002 Cameron, E. E. & Bushell, M.-J. A. (2021). Analysis of drug shortages across two countries during pre-pandemic and pandemic times. Research in Social and Administrative Pharmacy, 17(8), 1570–1573. https://doi.org/10.1016/j.sapharm.2020.12.001
  10. Central Bank of the Republic of Türkiye. (2026). Exchange rates. Retrieved July 13, 2026, from https://www.tcmb.gov.tr/wps/wcm/connect/EN/TCMB+EN/Main+Menu/Statistics/Exchange+Rates
  11. Chand, P., & Tarei, P. K. (2021). Do the barriers of multi-tier sustainable supply chain interact? A multi-sector examination using resource-based theory and resource-dependence theory. Journal of Purchasing and Supply Management, 27(5), 100722. https://doi.org/10.1016/j.pursup.2021.100722
  12. Cornelissen, N., Zielhuis, S. W., van den Bemt, P. M. L. A. & van den Bemt, B. J. F. (2026). Causes and management of drug shortages: A scoping review. Research in Social and Administrative Pharmacy, 22, 232–253. https://doi.org/10.1016/j.sapharm.2025.10.008
  13. Costa, N. L., & Ruas, C. M. (2026). Drug market in Brazil: An analysis of drug discontinuation from 2018 to 2022. Value in Health Regional Issues, 54, 101562. https://doi.org/10.1016/j.vhri.2025.101562
  14. Economist Impact. (2021). Global Health Security Index: Methodology. https://ghsindex.org/wp-content/uploads/2021/11/2021_GHSindex_Methodology_FINAL.pdf
  15. Fullman, N., Yearwood, J., Barber, M.R., Chalek, J., Eldrenkamp, E., Shields, C., Murray, C. J. L., & Lozano, R. (2018). Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016. The Lancet, 391(10136), 2236–2271. https://doi.org/10.1016/S0140-6736(18)30994-2
  16. Greco, S., Ishizaka, A., Tasiou, M., & Torrisi, G. (2019). On the methodological framework of composite indices: A review of the issues of weighting, aggregation, and robustness. Social Indicators Research, 141(1), 61-94. https://doi.org/10.1007/s11205-017-1832-9
  17. Güven, E. (2022). Türkiye’de sağlığın önemi ve dış ticaret hacminde ilaç ithalatı, ihracatı üzerine deterministik bir değerlendirme. Uluslararası Sağlık Yönetimi ve Stratejileri Araştırma Dergisi, 8(1), 95–111. https://izlik.org/JA72FD75BC
  18. Helfrich, S., & Grass, E. (2026). A defender-attacker-defender model for optimizing the resilience of hospital networks to cyberattacks. arXiv. https://doi.org/10.48550/arXiv.2601.11129
  19. Hu, Y., Zhang, W., Guh, D., & Anis, A. H. (2026). Impact of the U.S. 2025 tariff policy on Canadian pharmaceutical exports to the U.S. Health Policy, 167, 105594. https://doi.org/10.1016/j.healthpol.2026.105594
  20. Huang, L., Shan, D., & Chen, H. (2026). Artificial intelligence-driven improvement of hospital logistics management resilience: A practical exploration based on H Hospital. arXiv. https://doi.org/10.48550/arXiv.2603.13816
  21. Jian, J., Zhu, J., Gao, F., & Su, J. (2025). Government subsidy strategies for cross-border pharmaceutical supply chains under competitive environment. Asia Pacific Journal of Marketing and Logistics, 37(11), 3225-3252. https://doi.org/10.1108/APJML-11-2024-1607
  22. Karagöz, B. (2020). Tedarik zinciri risk ve belirsizlikleri: koronavirüs pandemisi ve ortaminda ilaç sektöründe risk yönetimi ve halkla ilişkiler. İstanbul Arel Üniversitesi İletişim Çalışmaları Dergisi, 8(17), 107-130. https://izlik.org/JA55LL22ZH
  23. Kruk, M. E., Myers, M., Varpilah, S. T., & Dahn, B. T. (2015). What is a resilient health system? Lessons from Ebola. The Lancet, 385(9980), 1910–1912. https://doi.org/10.1016/S0140-6736(15)60755-3
  24. Kruk, M. E., Ling, E. J., Bitton, A., Cammett, M., Cavanaugh, K., Chopra, M., El-Jardali, F., Macauley, R. J., Muraguri, M. K., Konuma, S., Marten, R., Martineau, F., Myers, M., Rasanathan, K., Ruelas, E., Soucat, A., Sugihantono, A., & Warnken, H. (2017). Building resilient health systems: A proposal for a resilience index. BMJ, 357, j2323. https://doi.org/10.1136/bmj.j2323
  25. Liu, S., & Ma, J. (2025). USA–China tariffs on pharmaceuticals affect global health equity. The Lancet, 405(10490), 1659-1660. https://doi.org/10.1016/ S0140-6736(25)00780-9
  26. Machta, R., Bosold, A., & Gerard, M. (2025). Defining and measuring the resilience, criticality, and vulnerability of medical product supply chains. U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation. https://aspe.hhs.gov/sites/default/files/documents/ebf67ed4c543fc5fa249ccbdd7a14391/MeasuringSupplyChainResilience.pdf
  27. Narayana, B. V. L. (2012). Resource dependency theory: Renaissance and extensions-A conceptual basis. https://doi.org/10.2139/ssrn.2015273
  28. Nardo, M., Saisana, M., Saltelli, A., Tarantola, S., Hoffman, A., & Giovannini, E. (2005). Handbook on constructing composite indicators: Methodology and user guide (OECD Statistics Working Papers No. 2005/03). OECD Publishing. https://doi.org/10.1787/533411815016
  29. Organisation for Economic Co-operation and Development, & Joint Research Centre. (2008). Handbook on constructing composite indicators: Methodology and user guide. OECD Publishing. https://doi.org/10.1787/9789264043466-en
  30. Organisation for Economic Co-operation and Development. (2023). Ready for the next crisis? Investing in health system resilience. OECD Publishing. https://doi.org/10.1787/1e53cf80-en
  31. Organisation for Economic Co-operation and Development. (2024). Securing medical supply chains in a post-pandemic world. OECD Publishing. https://doi.org/10.1787/119c59d9-en
  32. Organisation for Economic Co-operation and Development. (2025). Health at a glance 2025: OECD indicators. OECD Publishing. https://doi.org/10.1787/8f9e3f98-en
  33. Otobideh, S. A., Moeeni, S., Mohammadzadeh, Y., Rahimi, B., Shabaninejad, H., & Yusefzadeh, H. (2021). Estimation of the income and price elasticity of pharmaceutical import demand in Iran. International Journal of Pharmaceutical and Healthcare Marketing, 15(3), 466-474. https://doi.org/10.1108/IJPHM-05-2020-0045
  34. Özceylan, A. (2025). OECD ülkelerinde tedarik zinciri kırılganlığı ve dayanıklılığı. In Y. Fedai (Ed.), Endüstri mühendisliğinde yenilikçi yaklaşımlar ve yeni nesil mühendislik çalışmaları (1–24). Özgür Yayınları. https://doi.org/10.58830/ozgur.pub1092.c4340
  35. Pfeffer, J., & Salancik, G. R. (1978). The external control of organizations: A resource dependence perspective. University of Illinois at Urbana-Champaign, Academy for Entrepreneurial Leadership Historical Research Reference in Entrepreneurship. https://ssrn.com/abstract=1496213
  36. Semin, S., Güldal, D., & Demiral, Y. (2007). Globalization and the trends of medical technology trade in Turkey. Health Policy, 81(2-3), 320-327. https://doi.org/10.1016/j.healthpol.2006.07.002
  37. Tan, M. Z. Y., Prager, G., McClelland, A., & Dark, P. (2023). Healthcare resilience: A meta-narrative systematic review and synthesis of reviews. BMJ Open, 13(9), e072136. https://doi.org/10.1136/bmjopen-2023-072136
  38. Tbib, I., Zerei, S., Jellali, S., Ghozzi, N., Lassoued, I., Miled, S., & Hedhili, A. (2026). Pharmacoeconomic Impact of Purchasing Off-Label Drugs in Tunisia: Case Study of Pembrolizumab (Keytruda®). Clinical Therapeutics. 48(4), e1-17. https://doi.org/10.1016/j.clinthera.2026.02.004
  39. Toshev, A., Mihaylova, A. A., Madzharov, V., Petkova-Gueorguieva, E., Kirilov, B., Mirchev, D., & Gueorguiev, S. (2025). The European Union’s dependence on imports of active pharmaceutical ingredients from third countries–challenges and EU initiatives. Pharmacia, 72, 1-6. https://doi.org/10.3897/pharmacia.72.e172383
  40. Türk, H., & Güner, S. (2021). Türkiye’deki ilaç tedarik zinciri yapısı ve uygulamalarına ilişkin bir saha çalışması. Journal of Transportation and Logistics, 6(2), 177–196. https://doi.org/10.26650/JTL.2021.954832
  41. Turkish Statistical Institute. (2026). Gayri safi yurt içi hasıla ve kişi başına gayri safi yurt içi hasıla. Retrieved June 2, 2026, from https://www.tuik.gov.tr/
  42. United Nations. (2026). UN Comtrade database: Trade data. Retrieved July 13, 2026, from https://comtradeplus.un.org/
  43. T.C. Ministry of Health, 2024. Health statistics yearbook. https://www.saglik.gov.tr/TR-84930/saglik-istatistikleri-yilliklari.html
  44. Vural, I. E., Herder, M., & Graham, J. E. (2026). Competitive interdependence: A critical political economy of regulation during the COVID-19 pandemic. Social Science & Medicine, 391, 118759. https://doi.org/10.1016/j.socscimed.2025.118759
  45. Yeager, V. A., Menachemi, N., Savage, G. T., Ginter, P. M., Sen, B. P., & Beitsch, L. M. (2014). Using resource dependency theory to measure the environment in health care organizational studies: A systematic review of the literature. Health Care Management Review, 39(1), 50-65. https://doi.org/10.1097/HMR.0b013e3182826624
  46. World Health Organization. (2010). The world health report: Health systems financing: The path to universal coverage. https://www.who.int/publications/i/item/9789241564021
  47. World Health Organization. (2022). Health systems resilience toolkit: A WHO global public health good to support building and strengthening of sustainable health systems resilience in countries with various contexts. https://www.who.int/publications/i/item/9789240048751
  48. World Health Organization. (2024a). UHC service coverage index. Retrieved July 10, 2026, from https://data.who.int/indicators/i/3805B1E/9A706FD
  49. World Health Organization. (2024b). World Local Production Forum on enhancing access to medicines and other health technologies: Report of the second meeting, The Hague, Netherlands (Kingdom of the), 6–8 November 2023. https://www.who.int/publications/i/item/9789240097896
  50. World Health Organization. (2025). Responding to the health financing emergency: immediate measures and longerterm shifts. https://www.who.int/publications/b/81799
  51. World Health Organization. (2026a). Health systems resilience. Retrieved July 13, 2026, from https://www.who.int/teams/primary-health-care/health-systems-resilience
  52. World Health Organization. (2026b). Fiscal space for health, Retrieved September 22, 2026 from https://www.who.int/teams/health-financing-and-economics/health-financing/health-financing-policy/fiscal-space-for-health
  53. World Health Organization Regional Office for Europe, & European Observatory on Health Systems and Policies. (2024). Health Systems and Policy Monitor (HSPM). Retrieved July 10, 2026, from https://eurohealthobservatory.who.int/monitors/health-systems-monitor/overview
  54. Zhang, J., & Zhou, Z. (2025). The impact of US tariff hikes on health care. The Lancet, 405(10490), 1659. https://doi.org/10.1016/S0140-6736(25)00779-2